Clinical impact of hyperglycemia on days 0–7 after allogeneic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bone Marrow Transplantation

• Publication date

  2017-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2017.27PMID 28319076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

  2017cited by this paper
• How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT

  2016cited by this paper
• Metabolic Complications Precede Alloreactivity and are Characterized by Changes in ST2 Signaling

  2016cited by this paper
• Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

  2015cited by this paper
• The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

  2015cited by this paper
• Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT

  2015cited by this paper
• Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

  2014cited by this paper
• ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

  2013cited by this paper
• Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry

  2013cited by this paper
• Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease

  2012cited by this paper
• Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

  2012cited by this paper
• Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.

  2012cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.

  2010cited by this paper
• Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study

  2009cited by this paper
• Stress hyperglycaemia.

  2009cited by this paper
• Intensive versus Conventional Glucose Control in Critically Ill Patients

  2009cited by this paper
• Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*

  2009cited by this paper
• Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

  2009cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.

  2009cited by this paper
• Hyperglycemia During the Neutropenic Period Is Associated With a Poor Outcome in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

  2007cited by this paper
• Clinical practice. Management of hyperglycemia in the hospital setting.

  2006cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units

  2006cited by this paper
• Management of Hyperglycemia in the Hospital Setting

  2006cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

  2005cited by this paper
• Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.

  2003cited by this paper
• Intensive insulin therapy in critically ill patients.

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

  2001cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000cited by this paper
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective

  2022cites this paper
• Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

  2019influential citation
• Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT

  2018cites this paper
• Is adequate enteral nutrition associated with a similar outcome as adequate oral caloric intake after allogeneic transplantation?

  2018cites this paper
• Cure of Insulin-Dependent Diabetes Mellitusby an Autologous Hematopoietic StemCell Transplantation Performed to ControlMultiple Myeloma in a Patient with ChronicRenal Failure on Regular Hemodialysis

  2017cites this paper